HCMC – Vimedimex Medi – Pharma JSC (VMD) has announced that it will pay a 20% cash dividend, or VND2,000 per share, for the fiscal year 2022, with December 14 set as the record date.
With over 15.44 million outstanding shares, VMD will pay more than VND30 billion to existing shareholders on December 25.
Per its latest earnings report, the firm generated over VND2.9 trillion in revenue in January-September, down by 46.2% year-on-year.
The company demonstrated resilience with a 21.6% pickup in pre-tax profit, reaching VND29.05 billion, and a 26.73% increase in post-tax profit, totaling VND21.5 billion.
VMD attributed the improvement in profit to its strategic cost-cutting measures, with financial costs plunging by 72.2% to VND5 billion, sales costs falling more than half to VND162.57 billion, and business management costs dropping by 24% to VND36.9 billion.
In 2022, the company posted pre-tax profit of VND47.4 billion, surpassing expectations by 106%, while the undistributed profit after tax amounted to nearly VND37.9 billion.
Closing the trading session today, December 6, VMD inched up by 1.26% over the previous session to VND51,500.
With 359 winners and 122 losers, the VN-Index gained 10.46 points, or 0.94%, to 1,126.43 points.
The Hochiminh Stock Exchange saw 854 million shares valued at VND18 trillion changing hands, with block deals contributing 77.2 million shares and VND2.1 trillion to the total.
HAG took the lead by liquidity on the bourse, with nearly 34.5 million shares traded. It soared 5.9% to VND12,600 at the close.
The HNX-Index added 2.29 points, or 0.99%, to 233.63 points. Advancers outnumbered decliners by 105 to 62 on the Hanoi Stock Exchange, with a trading volume of 109.8 million shares and value of VND2.1 trillion.
